Everything below concerns circadian rhythm. We keep the language plain, cite what the science says, and separate well-supported claims from open questions.
Updated 2026-01-02. Numbers and descriptions here follow the published literature rather than marketing material.
Analytical chemists detect SR9009 with liquid chromatography-tandem mass spectrometry, commonly abbreviated LC-MS/MS. Sample preparation may involve protein precipitation, liquid-liquid extraction, or solid-phase extraction before analysis. Laboratories can target the parent compound or its metabolites, depending on the matrix and the purpose of testing. Anti-doping methods require sensitive and specific assays because concentrations in biological samples can be low. Reference standards and validated methods are essential for reliable identification and quantification.
Regulatory agencies have not approved SR9009 for human therapeutic use. It is typically sold as a research chemical with labels stating that it is not for human consumption. The World Anti-Doping Agency prohibits the substance in sport, generally under the category of non-approved substances. Customs and national laws may restrict importation, sale, or possession. Product quality and legal status can vary by country and vendor, and therapeutic claims are not permitted in regulated advertising because the compound lacks approval.
Several misconceptions surround SR9009. It is often described as a SARM, a steroid, or an exercise pill, but its known target is the REV-ERB receptor family. Rodent studies have examined exercise capacity and metabolic markers, yet human outcomes remain unproven. Oral bioavailability appears low in animals, and human pharmacokinetics are not well characterized. Online products may contain impurities or different compounds, so identity and purity testing are important for research use.
Analytical identification and purity assessment often use high-performance liquid chromatography with ultraviolet detection or mass spectrometry. Liquid chromatography–tandem mass spectrometry is used to detect and quantify SR9009 in biological matrices, including urine and blood, for anti-doping or pharmacokinetic studies. Nuclear magnetic resonance spectroscopy can confirm molecular structure. Stability depends on form and storage: the solid is generally more stable than solutions, and repeated freeze–thaw cycles may degrade samples. Purity is typically reported as a percentage from a certificate of analysis.
Regulatory treatment of SR9009 varies by country and context. It is not approved as a therapeutic drug by agencies such as the United States Food and Drug Administration or the European Medicines Agency. Sports authorities list it as a prohibited substance; the World Anti-Doping Agency classifies it among hormone and metabolic modulators. Legal status for personal possession or sale differs across jurisdictions, and some countries may restrict it under analog or research chemical laws. Buyers who seek verified material often rely on independent laboratory testing because online product labels may not match contents.
Laboratory samples of SR9009 are typically handled as research chemicals rather than pharmaceuticals. Suppliers usually state that the material is for research use only and not for human or veterinary administration. Storage recommendations generally call for a freezer at approximately −20 °C, protection from light, and a desiccated environment. The solid is often described as a white to off-white powder. Solubility is commonly reported in organic solvents such as dimethyl sulfoxide and ethanol, with low solubility in water.
| Property | Value | Notes |
|---|---|---|
| Regulatory status | Not approved for human use | Research-use-only status in many markets |
| WADA status | Prohibited in sport | Generally listed as a non-approved substance |
| Detection technique | LC-MS/MS | Common for urine and blood analysis |
| Common alias | Stenabolic | Informal market nickname, not a pharmacopoeial name |
| Purity check | HPLC or LC-UV | Independent certificate of analysis is typical |
Pharmacokinetic data for SR9009 are limited in published literature. Some reports indicate low oral bioavailability and rapid clearance in animals, which complicates interpretation of exposure and effect. Researchers often use injected routes in preclinical work to achieve measurable systemic levels. Analytical studies rely on mass spectrometry to detect the parent compound and its metabolites. Questions about tissue distribution, active metabolites, and long-term consequences remain open. Species differences in metabolism can affect observed half-life and target engagement.
SR9009 is a synthetic small molecule studied as an agonist of the nuclear receptors REV-ERBα and REV-ERBβ. These receptors help regulate circadian rhythms and metabolic gene expression. In laboratory experiments, SR9009 binds these receptors and alters transcription of genes involved in lipid handling, glucose metabolism, and mitochondrial function. It is not a naturally occurring compound and has no approved therapeutic use. Research interest stems from its ability to modify energy metabolism in cells and animal models.
In rodent studies, SR9009 has been reported to increase mitochondrial content in skeletal muscle and improve exercise endurance under some conditions. These findings led to popular descriptions such as an exercise mimetic, although that term oversimplifies the biology. Effects vary by dose, timing, tissue, and model. The compound's influence on circadian pathways means that time of administration can matter in experiments. Whether similar metabolic changes occur in humans remains largely unexplored in controlled published trials.
REV-ERB proteins typically suppress gene expression by recruiting corepressor complexes to DNA response elements. SR9009 binds these receptors and strengthens that repressive action in cell-based assays. Studies in rodents have reported changes in lipid handling, mitochondrial function, and exercise capacity after treatment. Such findings are often cited as evidence for metabolic effects, but species differences and limited pharmacokinetic data make direct translation to humans uncertain. Researchers continue to examine which effects are robust and which depend on specific experimental conditions.
SR9009 is frequently discussed alongside other REV-ERB ligands, including synthetic agonists and natural heme-related molecules. Its selectivity for REV-ERB over related nuclear receptors has been measured in binding and reporter assays, though off-target activity at higher concentrations is possible. The compound is prohibited in sport by the World Anti-Doping Agency, and it is not approved for any medical use in major jurisdictions. Products sold online may be labeled as research chemicals, and their identity and purity are not guaranteed by regulatory review.
Inflammatory abnormalities are a large group of disorders that underlie a vast variety of human diseases. The immune system is often involved with inflammatory disorders, as demonstrated in both allergic reactions and some myopathies, with many immune system disorders resulting in abnormal inflammation. Non-immune diseases with causal origins in inflammatory processes include cancer, atherosclerosis, and ischemic heart disease. Examples of disorders associated with inflammation include:
== Education and career == Brenner graduated from Wesleyan University with a bachelor's degree in biology in 1983. After working for the biotechnology companies Chiron Corporation and DNAX Research Institute, Brenner attended graduate school at Stanford University School of Medicine. At Stanford he worked with Robert S. Fuller, receiving his Ph.D. in Cancer Biology in 1993. Brenner conducted post-doctoral research at Brandeis University with Gregory Petsko and Dagmar Ringe. Brenner then joined the faculty at Thomas Jefferson University, where he worked from 1996 to 2003, becoming Director of the Structural Biology & Bioinformatics Program in 2000. He moved to Dartmouth Medical School in 2003, serving as associate director for Basic Sciences at Norris Cotton Cancer Center (now named Dartmouth Cancer Center) from 2003 to 2009. In 2009 he joined the University of Iowa (UI) as Professor and Head of Biochemistry. In 2010 he was awarded the Roy J. Carver Chair of Biochemistry at UI, holding that position until 2020. In 2020, Brenner joined City of Hope National Medical Center in Duarte, California as the inaugural chair of a new department of diabetes and cancer metabolism created to focus at the intersection of metabolic disturbances with diseases such as cancer and diabetes.
The pain in an osteoarthritic joint has been related to thickened synovium and to subchondral bone lesions. The inflammation of the joint lining (synovium) in osteoarthritis is characterized by involving macrophages via activation of the innate immune system (as compared to T-cell activation in the joint lining of people with rheumatoid arthritis). Pro-inflammation cytokines in osteoarthritis stimulate matrix metalloproteinases which leads to degradation and remodeling of the joint. Tissue damage or degradation of the articular cartilage or synovium leads to further release of inflammatory cytokines, driving the process.
==== 2010s ==== Every Paradise Bakery & Café location was rebranded in September 2015 as Panera Bread. In the fourth quarter of 2015, Panera acquired a majority stake in Tatte Bakery & Café, a bakery-cafe concept chain with locations in the Boston area, later opening in metro Washington D.C. On March 23, 2016, Panera opened its 2,000th location, a cafe in Elyria, Ohio. In January 2017, Panera announced its food menu was free of artificial colors, flavors, sweeteners, and preservatives. JAB Holding Company acquired the company on July 11, 2017, for $7.5 billion. On November 8, 2017, Panera announced that founder Ron Shaich was stepping down as CEO, and company president Blaine Hurst would take over. Shaich remained chairman. The company also announced the acquisition of Au Bon Pain. Panera divested Tatte Bakery & Café to Act III Holdings, LLC, owned by Shaich in January 2018. In January 2018, the company formed a consulting business to help restaurants remove artificial ingredients from their menus. On April 2, 2018, Brian Krebs reported that the Panera Bread website had leaked between 7 million and 37 million customer records— including names, email, and physical addresses, customer loyalty account numbers, birthdays, and last four digits of the customers' credit card numbers— for at least eight months before the site was taken offline. Panera was notified privately about the vulnerability in August 2017 but failed to fix it until after it was disclosed publicly eight months later. Panera said the leak affected fewer than 10,000 customers and had been fixed.
Sources: en.wikipedia.org
Because radon is quite electropositive for a noble gas, it is possible that radon fluorides actually take on highly fluorine-bridged structures and are not volatile. Extrapolation down the noble gas group would suggest also the possible existence of RnO, RnO2, and RnOF4, as well as the first chemically stable noble gas chlorides RnCl2 and RnCl4, but none of these have yet been found. Radon carbonyl (RnCO) has been predicted to be stable and to have a linear molecular geometry. The molecules Rn2 and RnXe were found to be significantly stabilized by spin-orbit coupling. Radon caged inside a fullerene has been proposed as a drug for tumors. Despite the existence of Xe(VIII), no Rn(VIII) compounds have been claimed to exist; RnF8 should be highly unstable chemically (XeF8 is thermodynamically unstable). Radon reacts with the liquid halogen fluorides ClF, ClF3, ClF5, BrF3, BrF5, and IF7 to form RnF2. In halogen fluoride solution, radon is nonvolatile and exists as the RnF+ and Rn2+ cations; addition of fluoride anions results in the formation of the complexes RnF3− and RnF42−, paralleling the chemistry of beryllium(II) and aluminium(III). The standard electrode potential of the Rn2+/Rn couple has been estimated as +2.0 V, although there is no evidence for the formation of stable radon ions or compounds in aqueous solution.
== Simple flow models == Design equations are equations relating the space time to the fractional conversion and other properties of the reactor. Different design equations have been derived for different types of the reactor and depending on the reactor the equation more or less resemble that describing the average residence time. Often design equations are used to minimize the reactor volume or volumetric flow rate required to operate a reactor.
Eliot, Ezra Pound, William Carlos Williams, Basil Bunting, Gertrude Stein, Francis Picabia, Yvor Winters; was daughter of Hungarian Jewish tailor, Sigmund Felix Lowy, who had moved to London to evade persistent antisemitism in Budapest, and Christian, English mother. Michael Hamburger OBE poet and translator Anna Mendelssohn (born Anna Mendleson, 1948 – 15 November 2009), who wrote under the name Grace Lake, was prolific writer, poet, artist and political activist with The Angry Brigade; was inspired by the Paris student risings in May 1968, and became political radical in Britain; later studied poetry at St Edmund's College, Cambridge, devoting her life to poetry and art; became opposed to technology, disliking judgments based on rationality in favour of those based on artistic judgment. Vivian de Sola Pinto, poet John Rodker, poet and publisher Isaac Rosenberg, war poet Leon Rosselson, radical singer, songwriter and children's book author. Siegfried Sassoon, writer and WW1 poet, of Iraqi Jewish Mizrahi Jewish origin. Henry Shukman (born 1962 in Oxford, Oxfordshire); poet and writer; father was historian Harold Shukman; brother is BBC News reporter David Shukman. Jon Silkin, poet Stephen Spender (28 February 1909 – 16 July 1995); poet, novelist and essayist whose work concentrated on themes of social injustice and the class struggle; son of Harold Spender (22 June 1864 – 15 April 1926), Liberal Party politician, author, journalist and lecturer of German Jewish ancestry.
Point-of-care ultrasound (POCUS) may be useful in the diagnosis of NF when MRI and CT are unavailable. It can also help rule out diagnoses that mimic earlier stages of NF, including deep vein thrombosis (DVT), superficial abscesses, and venous stasis. Linear probes are generally preferred for the assessment, especially in the extremities. Findings characteristic of NF include abnormal thickening, air, or fluid in the subcutaneous tissue. This can be summarized as the mnemonic "STAFF" (Subcutaneous irregularity or Thickening, Air, and Fascial Fluid). The official diagnosis of NF using ultrasound requires "the presence of BOTH diffuse subcutaneous thickening AND fascial fluid more than 2 mm." Gas in the subcutaneous tissue may show "dirty acoustic shadowing." However, similar to other imaging modalities, the absence of subcutaneous free air does not definitively rule out a diagnosis of NF, because this is a finding that often emerges later in the disease process. Of note, the quality and accuracy of POCUS are highly user-dependent. It may also be difficult to visualize NF over larger areas, or if there are many intervening layers of fat or muscle. It is still unclear whether POCUS improves the speed of diagnosis of NF or if it reduces the time to surgical intervention as a whole.
He appears as the lover of the Lady of the Lake, who bequeaths a powerful sword to Geralt. In the 2023 Warhammer 40,000 novel The Lion: Son of the Forest by Mike Brooks, the protagonist Lion El'Jonson (a character heavily inspired by King Arthur) encounters a wounded king fishing by a lake in a mysterious, alternate dimension. This figure serves as an allegory for the Fisher King, representing the setting's grievously wounded ruler, the Emperor of Mankind.
Sources: en.wikipedia.org
Legality depends on the country and the intended use. In many places it is not approved as a medicine and may be sold only as a research chemical. Importation or possession can be restricted, and sports organizations prohibit it.
Anti-doping laboratories typically use LC-MS/MS to detect SR9009 or its metabolites in urine or blood. The exact assay depends on the laboratory and the testing program. Detection can be challenging because the compound may be rapidly metabolized and present at low levels.
Stenabolic is an informal nickname used in online fitness and research-chemical markets, not an official drug name. It likely references reported effects on endurance in rodent studies. The nickname does not imply approval or proven human benefit.
Legality depends on the country and the intended use. In many places it is sold as a research chemical, but sports and medicine regulations restrict it.